Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 282, Issue 2 26-2, 2002, Pages

  Schultz, Marc J ^a   Rijneveld, Anita W ^a   Florquin, Sandrine ^a   Edwards, Carl K ^b   Dinarello, Charles A ^c   Van Der Poll, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMGEN INC   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokines; Tumor necrosis factor

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; LUNG FUNCTION; LUNG INFECTION; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 0036084620     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00461.2000     Document Type: Article

References (31)

1. Effects of interleukin-1 receptor antagonist in a slow-release hylan vehicle on rat type II collagen arthritis
2. Combination benefit of treatment with the cytokine inhibitors interleukin- 1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis
3. Interleukin-1 receptor type I gene-deficient mice are less susceptible to Staphylococcus epidermidis biomaterial-associated infection than are wild-type mice
4. Compartmentalized cytokine production within the human lung in unilateral pneumonia
5. Biologic basis for interleukin- 1 in disease
6. Phenotypic and functional characterization of mice that lack the type I receptor for IL- 1
7. Neutralization of IL- 10 increases survival in a murine model of Klebsiella pneumonia
8. Neutralization of macrophage inflammatory protein- 2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia
9. Type I IL- 1 receptor blockade exacerbates murine listeriosis
10. Pathogens causing nosocomial infections
11. Nosocomial infection surveillance 1984
12. Interleukin- 1 signaling is essential for host defense during murine pulmonary tuberculosis
13. Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats
14. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense
15. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
16. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia
17. Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats
18. Role of cytokines in pulmonary antimicrobial host defense
19. Acute bacterial pneumonia in rats increases alveolar epithelial fluid clearance by a tumor necrosis factor-α-dependent mechanism
20. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice
21. IL- 10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia
22. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice
23. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia
24. The role of cytokines in the pathogenesis of pneumonia
25. Interleukin- 1 beta in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema
26. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa
27. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice
28. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 α/β and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation
29. The intratracheal administration of endotoxin and cytokines. I. Characterization ofLPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate
30. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation
31. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice